Looks Health Financials

BSE: 534422

₹9.97

₹-0.07 (-0.70%)

As on 08-Sep-2026IST

Market cap

₹10 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

455.6

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	0.44	0.39	0.39	--	0.01	--
Total Income	0.44	0.39	0.79	0.46	0.46	0.44
Total Expenditure	0.27	0.22	0.61	0.34	0.42	0.26
EBITDA	0.17	0.17	-0.22	-0.34	-0.42	-0.26
Depreciation	0.14	0.14	0.14	0.14	0.14	0.14
EBIT	0.03	0.03	-0.36	-0.48	-0.56	-0.40
Interest	0.00	0.00	--	--	--	0.00
Other Income	0.00	0.00	0.39	0.46	0.45	0.44
Exceptional Items	--	--	--	--	0.00	0.00
Profit before Tax	0.03	0.03	0.03	-0.02	-0.10	0.04
Provision for Tax	0.01	0.01	0.01	-0.01	0.06	0.01
Profit after Tax	0.02	0.02	0.02	-0.02	-0.16	0.03

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	14.85	14.85	14.83	14.80	14.82	14.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.85	0.84	0.02	0.04	0.06	0.08
Current Liabilities	0.41	0.42	0.14	0.02	0.00	0.03
Total Liabilities	16.11	16.11	14.98	14.86	14.88	15.09

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	0.23	14.86	14.16	14.64	14.59	14.84
Current Assets	1.23	1.24	0.82	0.22	0.29	0.25
Total Assets	16.11	16.11	14.98	14.86	14.88	15.09
Total Debt*	--	--	--	--	--	--
Net Current Assets	0.83	0.83	0.68	0.20	0.29	0.22
Contingent Liabilities	--	0.08	0.08	0.08	0.08	0.08

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	0.89	-0.50	-0.35	-0.42	-0.33
Cash Flow from Investing Activities	--	-0.85	0.73	0.27	0.45	0.34
Cash from Financing Activities	--	0.85	--	--	--	--
Net Cash Inflow / Outflow	--	0.89	0.22	-0.08	0.03	0.02

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS (₹)	0.02	0.02	0.02	-0.02	-0.15	0.03
Cash EPS (₹)	0.02	0.16	0.16	0.12	-0.02	0.17
Adjusted Book Value (₹)	14.14	14.14	14.12	14.10	14.11	14.27
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.84	-0.48	-0.33	-0.40	-0.31
Free Cash Flow per Share (₹)	--	0.83	-0.11	0.11	-0.03	0.15

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	0.22	0.20	-0.16	-0.69	0.26
ROE (%)	0.15	0.16	0.16	-0.12	-1.07	0.21
ROA (%)	0.15	0.15	0.16	-0.12	-1.07	0.21
EBIT Margin (%)	7.26	7.35	-91.61	--	-7,453.33	--
Net Margin (%)	5.20	6.00	3.04	-3.87	-34.53	7.22
Cash Profit Margin (%)	0.00	42.58	41.96	--	-237.33	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	-5.16	-1.70	--	-100.00	--	-100.00
EBIT Growth (%)	117.20	107.88	24.85	13.92	-38.71	37.85
Net Profit Growth (%)	-70.51	-1.67	235.03	88.91	-600.31	118.48
EPS Growth (%)	-70.52	-1.75	234.91	88.88	-600.00	118.49
Book Value Growth (%)	--	0.16	0.16	-0.12	-1.07	0.21

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	455.61	295.98	203.51	--	--	369.41
Price / Book Value	0.71	0.47	0.33	0.30	0.27	0.79
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	53.06	33.13	26.76	36.65	101.99	64.45
Close Price (₹)	9.03	6.63	4.64	4.20	3.80	11.23
High Price (₹)	10.94	10.52	6.69	8.48	13.21	32.95
Low Price (₹)	3.57	3.57	3.81	3.75	3.75	6.40
Market Cap (₹ Cr)	10.48	6.96	4.87	--	3.99	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	3.02	2.98	6.05	10.75	67.30	7.90
Quick Ratio	3.02	2.98	6.05	10.75	67.30	7.90
Interest Coverage	33.00	36.00	--	--	--	389.00

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	--	--	100.00	--	--	--
Asset Turnover	0.03	0.03	0.03	--	0.00	--
Receivable days	--	--	365.00	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.